NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients

Aug 18th 2025 4:14pm EDT

by Nicolas Hulscher, MPH Fenbendazole (FBZ) is a low-cost veterinary antiparasitic drug that has gained global attention as a potential anticancer therapy. Like ivermectin—another antiparasitic widely repurposed in research and clinical practice for its potent anti-tumor effects—fenbendazole appears to work far beyond its original veterinary use. Preclinical studies show fenbendazole disrupts cancer cell survival through […]

Discuss on Nostr!

Nostr Note ID note13f24er6hz5jsgp7y7l6fdwqmh6sunsdc74k6qp36eznzra8ackzqfehsp8 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social

New to Nostr?
Create an account now & join the conversation!

Promote it on DissentWatch!

  • To advertise this post for $0.02 per visit send bitcoins to the address below
  • The post will be promoted daily via social media & our "Featured News" display in multiple places
  • You can add more anytime
  • Ranking order in the Featured News box is based on the balance remaining


Received: 0 mBTC (0.00 USD)

Spent: 0 mBTC (0.00 USD)

Balance: 0 mBTC (0.00 USD)

The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.

REFRESH AMOUNTS